Journals / Gülhane Tıp Dergisi / 2020 / Cilt: 62 - Sayı: 4

Osteoradionecrosis - a review of clinical features and management

Pages
213–223
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, the present review highlights the clinical features and risk factors associated as well as the various methods used in the treatment of ORN.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Radiotherapy is an important part of oral cancer management.
📊
Key Findings & Data:A significant complication of radiotherapy to the head and neck is osteoradionecrosis (ORN).
💡
Conclusion & Impact:In conclusion, the present review highlights the clinical features and risk factors associated as well as the various methods used in the treatment of ORN.
🔬Design:Review & Systematic Survey
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Özet

Radiotherapy is an important part of oral cancer management. A significant complication of radiotherapy to the head and neck is osteoradionecrosis (ORN). The present report reviews the risk factors, clinical features, and management of ORN affecting the maxilla and mandible. A “PubMed” database search was done to identify “case reports” of ORN that were published, using the keywords “osteoradionecrosis”, “jaw’”, “mandible” and “maxilla”. Data on ORN published within the past 10 years from 2008 to 2018 were collected and analyzed. A total of 23 full text articles reporting 27 cases of ORN were identified. Males constituted 84% of the cases. The mandible was affected in 96% of cases with bilateral involvement in 26.9% of cases and posterior mandibular involvement in 53.8% of cases. The amount of radiation received ranged from 50 Gy to 77 Gy. ORN occurred in 3.87 years on average after radiotherapy. The highest risk of developing ORN was associated with extraction of mandibular teeth within the radiation field in patients who received a radiation dose greater than 60 Gy. ORN was managed using varied methods such as surgical therapy, reconstruction with free fibular graft, low level laser therapy, and platelet rich gel. The recurrence of ORN was reported in 22% cases ranging from three weeks to one year later. In conclusion, the present review highlights the clinical features and risk factors associated as well as the various methods used in the treatment of ORN. The use of preventive strategies and advanced methods of management can decrease the incidence of ORN.

🔖

Cite This Article

AJİLA, V., HEGDE, S. (2020). Osteoradionecrosis - a review of clinical features and management. Gülhane Tıp Dergisi, Cilt: 62 - Sayı: 4, 213–223. https://ajindex.com/articles/225226

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hypponen E. Vitamin D and chronic widespread pain in a white middle-aged british population: Evidence from a cross-sectional population survey. Ann Rheum Dis. 2009;68:817-822
  2. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA. Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol. 2007;26:1895-1901
  3. Mouyis M, Ostor AJ, Crisp AJ, et al. Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology. 2008;47:1348-1351
  4. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78:1463-1470
  5. Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008;29:369-375
  6. Cutolo M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther. 2008;10:123
  7. Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010;9:507-510
  8. Haroon M, Bond U, Quillinan N, Phelan MJ, Regan MJ. The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics. Clinical Rheumatology. 2010;30:789- 794
  9. Erten S, Kucuksahin O, Sahin A, Altunoglu A, Akyol M, Koca C. Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis. Intern Med. 2013;52:339-344
  10. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007;7:59-64
  11. Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012;3:181-187
  12. Grazio S, Naglić DB, Anić B, et al. Vitamin D serum level, disease activity and functional ability in different rheumatic patients. Am J Med Sci. 2015;349:46-49
  13. Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014;39:322-350
  14. Quraishi MK, Badsha H. Rheumatoid arthritis disease activity and vitamin D deficiency in an Asian resident population. Int J Rheum Dis. 2016;19:348-354
  15. Sahebari M, Mirfeizi Z, Rezaieyazdi Z, Rafatpanah H, Goshyeshi L. 25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DAS28 ESR). Caspian J Intern Med. 2014;5:148-155
  16. Merlino LA, Curtis J, M